Clinical Trials on ADHD in Germany

Total 27 results

University of Cologne

Unknown

Efficacy of Omega-3/Omega-6 Fatty Acids in Pre-school Children at Risk for ADHD

Children With ADHD Symptoms >90th Percentile (FBB-ADHS-V); no Beginning or Completion of Psychotherapeutically or Psychopharmalogical Treatment During the Study

Germany
RWTH Aachen University

Completed

Network Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD (CAIAC)

ADHD

Germany
Philipps University Marburg Medical Center

Unknown

Neurofeedback Study ADHD

ADHD

Germany
Eli Lilly and Company

Completed

Treatment Compliance in Children and Adolescents on ADHD Medication (COMPLY)

ADHD

Germany
Prof. Huss
Steiner Arzneimittel, Berlin, Germany

Completed

Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD

ADHD

Germany
Prof. Huss

Terminated

Adherence to Stimulant Treatment in Attention-Deficit Hyperactivity Disorder (ADHD) Patients (ASTA) (ASTA)

ADHD

Germany
Hospital Vall d'Hebron
Semmelweis University; University Medical Center Nijmegen; University Hospital...

Completed

Treating Impulsivity in Adults With Probiotics (PROBIA)

ADHD | Impulsive Behavior | Borderline Personality Disorder | Compulsive Disorder

Spain, Hungary, Germany
Wuerzburg University Hospital
German Research Foundation

Completed

Genetic Modulation of Working Memory in Attention Deficit Hyperactivity Disorder (ADHD) (BEAS)

ADHD

Germany
University of Cologne

Unknown

Effects of Playtraining in ADHD Preschoolers on ADHD Symptoms and Play Persistence and Intensity

ADHD

Germany
Novartis

Completed

Placebo-Controlled Comparison of Two Different Brands of Modified-Release Oral Dosage Forms Regarding Safety and Efficacy in Children With Attention Deficit Hyperactivity Disorder (ADHD) Aged 6 - 14

ADHD

Germany
Shire

Completed

Drug Use Study With Intuniv® in European Countries

Attention Deficit Hyperactivity Disorder (ADHD)

Germany
University Hospital Tuebingen

Completed

Evaluation of a Group Therapeutic Exercise Program

Depression | Anxiety Disorders | ADHD | Primary Insomnia

Germany
Johannes Gutenberg University Mainz
Engelhard Arzneimittel GmbH & Co.KG

Terminated

Efficacy Study of Polyunsaturated Fatty Acids in Children and Adolescents With Attention Deficit/ Hyperactivity Disorder (PAD)

ADHD

Germany
Shire

Completed

Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17

ADHD

Belgium, France, Germany, Hungary, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
Shire

Completed

Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17

ADHD

Germany, Hungary, Italy, Poland, Sweden, United States, United Kingdom, Belgium, France
Takeda

Recruiting

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life (LANDSCAPE)

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Canada, Sweden
Otsuka Pharmaceutical Europe Ltd

Completed

An Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADH (SAMPLE)

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

Germany, Spain
NHS Tayside
Zentralinstitut für Seelische Gesundheit Mannheim; Universita degli Studi di... and other collaborators

Completed

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE)

Attention Deficit Hyperactivity Disorder (ADHD)

United Kingdom, Germany, Hungary, Italy
RWTH Aachen University
Philips Technology Aachen Germany

Unknown

Acute Congestive Heart Failure (AcuteCHF)

Acute Decompensated Heart Failure (ADHF) | Acute Cardiogenic Pulmonary Edema (ACPE)

Germany
Sanofi

Completed

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Hyponatremia | Syndrome of Inappropriate ADH (SIADH) Secretion

France, Germany, Belgium, Hungary
Otsuka Pharmaceutical Development & Commercialization...
Otsuka Pharmaceutical Co., Ltd.

Completed

"SALT-2 Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia

Hyponatremia | Inappropriate ADH Syndrome | Water Intoxication | Water-electrolyte Imbalance

Germany
Shire

Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
Shire

Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

Germany, Italy, Poland, Spain, Romania, Belgium, Hungary, Netherlands, Sweden, United Kingdom
Sanofi

Completed

Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Hyponatremia | Inappropriate ADH Syndrome

United States, Canada, Brazil, Germany, Netherlands, Portugal, Spain, Belgium, Croatia, Hungary, Hong Kong
Sanofi

Completed

Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH Safety)

Hyponatremia | Inappropriate ADH Syndrome

United States, France, Brazil, Russian Federation, Australia, Germany, Switzerland, Belgium, Hungary, Hong Kong, Canada
Otsuka Pharmaceutical Development & Commercialization...

Completed

A PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)

Germany, United Kingdom, Spain, Sweden, Hungary, Czech Republic, Denmark
Institut de Recherches Internationales Servier
Celgene Corporation

Active, not recruiting

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) With an IDH1 and/or IDH2 Mutation

Untreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic Injury

United States, Germany, Netherlands

Clinical Trials on ADHD in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Türkiye

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations